| xCell: digitally portraying the tissue cellular heterogeneity landscape D Aran, Z Hu, AJ Butte Genome Biology 18, 220, 2017 | 3312 | 2017 |
| Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage D Aran, AP Looney, L Liu, E Wu, V Fong, A Hsu, S Chak, RP Naikawadi, ... Nature immunology 20 (2), 163-172, 2019 | 3167 | 2019 |
| Systematic pan-cancer analysis of tumour purity D Aran, M Sirota, AJ Butte Nature communications 6 (1), 8971, 2015 | 1083 | 2015 |
| Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer DY Oh, SS Kwek, SS Raju, T Li, E McCarthy, E Chow, D Aran, A Ilano, ... Cell 181 (7), 1612-1625. e13, 2020 | 565 | 2020 |
| Comprehensive analysis of normal adjacent to tumor transcriptomes D Aran, R Camarda, J Odegaard, H Paik, B Oskotsky, G Krings, A Goga, ... Nature communications 8 (1), 1077, 2017 | 523 | 2017 |
| Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood G Toperoff, D Aran, JD Kark, M Rosenberg, T Dubnikov, B Nissan, ... Human molecular genetics 21 (2), 371-383, 2012 | 397 | 2012 |
| DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes D Aran, S Sabato, A Hellman Genome biology 14, 1-14, 2013 | 387 | 2013 |
| Replication timing-related and gene body-specific methylation of active human genes D Aran, G Toperoff, M Rosenberg, A Hellman Human molecular genetics 20 (4), 670-680, 2011 | 370 | 2011 |
| Cross-tissue analysis of gene and protein expression in normal and cancer tissues I Kosti, N Jain, D Aran, AJ Butte, M Sirota Scientific reports 6 (1), 24799, 2016 | 210 | 2016 |
| DNA methylation of transcriptional enhancers and cancer predisposition D Aran, A Hellman Cell 154 (1), 11-13, 2013 | 199 | 2013 |
| CNS fibroblasts form a fibrotic scar in response to immune cell infiltration CE Dorrier, D Aran, EA Haenelt, RN Sheehy, KK Hoi, L Pintarić, Y Chen, ... Nature neuroscience 24 (2), 234-244, 2021 | 162 | 2021 |
| Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types K Yu, B Chen, D Aran, J Charalel, C Yau, DM Wolf, LJ Van ‘T Veer, ... Nature communications 10 (1), 3574, 2019 | 139 | 2019 |
| Cell-type enrichment analysis of bulk transcriptomes using xCell D Aran Bioinformatics for cancer immunotherapy: methods and protocols, 263-276, 2020 | 117 | 2020 |
| Widespread parainflammation in human cancer D Aran, A Lasry, A Zinger, M Biton, E Pikarsky, A Hellman, AJ Butte, ... Genome biology 17, 1-14, 2016 | 112 | 2016 |
| Aging is associated with highly defined epigenetic changes in the human epidermis G Raddatz, S Hagemann, D Aran, J Söhle, PP Kulkarni, L Kaderali, ... Epigenetics & chromatin 6, 1-12, 2013 | 96 | 2013 |
| Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2 E Petter, O Mor, N Zuckerman, D Oz-Levi, A Younger, D Aran, Y Erlich MedRxiv, 2021.02. 08.21251329, 2021 | 83 | 2021 |
| CD161 contributes to prenatal immune suppression of IFN-γ–producing PLZF+ T cells J Halkias, E Rackaityte, SL Hillman, D Aran, VF Mendoza, LR Marshall, ... The Journal of clinical investigation 129 (9), 3562-3577, 2019 | 69 | 2019 |
| Molecular programs of fibrotic change in aging human lung S Lee, MN Islam, K Boostanpour, D Aran, G Jin, S Christenson, ... Nature communications 12 (1), 6309, 2021 | 56 | 2021 |
| Comparison of FOLFIRINOX vs gemcitabine plus nab-paclitaxel as first-line chemotherapy for metastatic pancreatic ductal adenocarcinoma A Klein-Brill, S Amar-Farkash, G Lawrence, EA Collisson, D Aran JAMA network open 5 (6), e2216199-e2216199, 2022 | 54 | 2022 |
| Estimating real-world COVID-19 vaccine effectiveness in Israel using aggregated counts D Aran MedRxiv, 2021.02. 05.21251139, 2021 | 52 | 2021 |
Atul J. ButteDirector, Bakar Computational Health Sciences Institute, University of California, San FranciscoEmail verificata su ucsf.edu
